Biographical Sketch
Mark Niebauer, MD is a staff cardiologist in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Section of Cardiac Electrophysiology and Pacing at the Cleveland Clinic. Dr. Niebauer has a special interest in cardiac defibrillation and catheter cryoablation.
Dr. Niebauer earned a BS in Chemistry from Ball State University, Muncie, Ind., and a Master's in Biology followed by a PhD in Physiology from Purdue University. His PhD research was on cardiac defibrillation. After receiving his PhD, he was a research fellow with the American Heart Association and the National Institutes of Health at the University of Nebraska before entering medical school at Creighton University, Omaha.
Dr. Niebauer received his medical degree in 1988 and went on to serve his residency in internal medicine at the University of Michigan followed by fellowships in cardiovascular medicine and cardiac electrophysiology. He was on the Cleveland Clinic staff from 1995 to 2002, rejoining the staff in 2008 from the University of Nebraska Medical Center where he was Director of Cardiac Electrophysiology and an Associate Professor of Medicine.
A fellow of the American College of Cardiology since 1997, Dr. Niebauer also is a member of the Heart Rhythm Society, the Cardiac Electrophysiology Society and the American Heart Association Clinical Cardiology Scientific Council. In addition, he serves as scientific advisor to Cryocath, Inc. and St. Jude Medical, Inc. He also serves as a data safety board member for Ablation Frontiers, Inc.
Dr. Niebauer is board-certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology. He has authored over one hundred papers and abstracts in leading scientific journals and is a frequent speaker at national and international conferences related to cardiac electrophysiology and defibrillation.
Specialty Interests
electrophysiology, radiofrequency ablation, implantable defibrillators
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with
the pharmaceutical or medical device industries to help develop
medical breakthroughs or provide medical education about recent
trends. The collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with which
they collaborate. The Cleveland Clinic requires its doctors
to approve the public disclosures of their scientific
collaborations with industry. As of 10/24/2008 the review
process regarding Dr. Niebauer’s disclosure had not been
completed. Patients should feel free to contact their doctor
about any of the relationships and how the relationships are
overseen by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with industry
and innovation management, go to our
Integrity in Innovation page.
